Removal of skin tags: scissor excision versus non-ablative 532nm-LBO-laser in a randomized intraindividual controlled observer-blinded clinical trial : Laser is not always better.
Summary
In a randomized intraindividual, observer-blinded trial of 68 patients (1,257 lesions), scissor snip excision achieved higher complete healing at 12 weeks (85% vs 71%), lower pain, and greater patient preference than a non-ablative 532 nm LBO laser. Although laser treatment was faster and bloodless, it had more erythema and pigmentary changes, supporting scissor excision as first-line therapy for skin tags.
Key Findings
- Complete healing at 12 weeks: 85% (scissor) vs 71% (532 nm LBO laser), p=0.00001
- Lower pain scores with scissor excision (mean 2.6) vs laser (mean 3.42)
- Patient preference favored scissor excision (63% vs 19% for laser; 18% indifferent)
- Laser was ~39% faster but had higher rates of erythema and hyper/hypopigmentation
Clinical Implications
Prefer scissor snip excision as first-line for pedunculated fibromas; counsel patients that lasers may be faster but carry higher risk of erythema and pigment changes and do not improve healing.
Why It Matters
This RCT provides high-quality evidence that challenges the assumption that lasers are superior for skin tag removal and supports a simpler, lower-cost approach.
Limitations
- Single-center study with short follow-up (12 weeks)
- Limited to neck/axilla skin tags and a single non-ablative 532 nm LBO laser modality
Future Directions
Head-to-head trials with other laser modalities and longer-term outcomes (pigmentary/scar durability), cost-effectiveness analyses, and evaluation in diverse anatomical sites and skin phototypes.
Study Information
- Study Type
- RCT
- Research Domain
- Treatment
- Evidence Level
- I - Randomized, observer-blinded, intraindividual controlled clinical trial
- Study Design
- OTHER